Results 1 to 10 of about 187,156 (185)

A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy [PDF]

Health and Quality of Life Outcomes
Objective Oral anticoagulant therapy is widely used for the prevention and treatment of thromboembolic diseases, yet it imposes significant burdens on patients’ health-related quality of life (HRQoL).
Shujie Dong, Yajing Li, Ziqiong Liao, Qi Lin, Hei Hang Edmund Yiu, Wai-kit Ming, Lei Li, Rongsheng Zhao   +7 more
doaj   +2 more sources

Oral anticoagulant therapy

Indian Journal of Dental Research, 2012
Pankaj Agarwal
doaj   +3 more sources

Retroperitoneal hematoma: An unexpected complication of anticoagulant therapy in COVID-19 patients [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2023
Introduction. Coronavirus disease 2019 (COVID-19) is associated with high inflammatory response, hemostatic disturbances, and high thrombotic risk. Despite thromboprophylaxis, a high incidence of thromboembolic events has been reported with a consequent ...
Vasković Igor, Udovičić Ivo, Stojić Mihailo, Arsenović Ljiljana, Nešković Vojislava   +4 more
doaj   +1 more source

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis

Scientific Reports, 2022
Disseminated intravascular coagulation (DIC) is one of the major organ dysfunctions associated with sepsis. This retrospective secondary analysis comprised data from a prospective multicenter study to investigate the age-related differences in the ...
Takeshi Wada, Kazuma Yamakawa, Daijiro Kabata, Toshikazu Abe, Hiroshi Ogura, Atsushi Shiraishi, Daizoh Saitoh, Shigeki Kushimoto, Seitaro Fujishima, Toshihiko Mayumi, Toru Hifumi, Yasukazu Shiino, Taka-aki Nakada, Takehiko Tarui, Yasuhiro Otomo, Kohji Okamoto, Yutaka Umemura, Joji Kotani, Yuichiro Sakamoto, Junichi Sasaki, Shin-ichiro Shiraishi, Kiyotsugu Takuma, Ryosuke Tsuruta, Akiyoshi Hagiwara, Tomohiko Masuno, Naoshi Takeyama, Norio Yamashita, Hiroto Ikeda, Masashi Ueyama, Satoshi Fujimi, Satoshi Gando   +30 more
doaj   +1 more source

The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysisResearch in context

EClinicalMedicine, 2023
Summary: Background: The optimal duration of anticoagulation in patients with active cancer and venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate anticoagulant therapy for 3–6 months and to continue anticoagulant therapy for ...
Marte A.M. van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, Wichor M. Bramer, Aneel A. Ashrani, Jean-Luc Bosson, Daniel J. Crusan, Andrea D'Alessio, Meg E. Fluharty, Valdis Ģībietis, Per-Olof Hansson, Nobuhiro Hara, Luis Jara-Palomares, Noémie Kraaijpoel, Isabelle Mahé, Andrea Marshall, Yutaka Ogino, Remedios Otero, Jorie Versmissen, Frederikus A. Klok, Marieke J.H.A. Kruip, Carin C.D. van der Rijt, Eric C.T. Geijteman   +22 more
doaj   +1 more source

Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study

Frontiers in Medicine, 2021
Background: Patients with splenic infarction (SI) are associated with a prothrombotic state and are vulnerable to subsequent thromboembolic complications. However, due to its rarity, there is no established treatment modality in this population. We aimed
Chieh-Ching Yen, Chieh-Ching Yen, Chih-Kai Wang, Chih-Kai Wang, Chung-Hsien Chaou, Chung-Hsien Chaou, Chung-Hsien Chaou, Shou-Yen Chen, Shou-Yen Chen, Shou-Yen Chen, Jhe-Ping Lin, Jhe-Ping Lin, Chip-Jin Ng, Chip-Jin Ng   +13 more
doaj   +1 more source

Magnitude of hemorrhagic complications and its associated factors among patients on anticoagulant therapy at University of Gondar Comprehensive and Specialized Hospital, Northwest Ethiopia

Thrombosis Update, 2023
Background: Despite the well-established effectiveness of anticoagulants, the risk of their hemorrhagic complications withheld many patients from being maintained on anticoagulant therapy. However, there is no sufficient data on the magnitude and factors
Eden Abetu Mehari, Abebe Basazn Mekuria, Mestayet Geta, Eshetie Melese Birru   +3 more
doaj   +1 more source

The year in cardiology: arrhythmias and pacing. [PDF]

, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H, Camm, AJ, Lip, GYH, Schilling, R, Steffel, J   +4 more
core   +4 more sources

Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study

Journal of Intensive Care, 2023
Background The development of disseminated intravascular coagulation (DIC) in patients with sepsis has been repeatedly confirmed as a factor associated with poor prognosis.
Takeshi Wada, Kazuma Yamakawa, Daijiro Kabata, Toshikazu Abe, Seitaro Fujishima, Shigeki Kushimoto, Toshihiko Mayumi, Hiroshi Ogura, Daizoh Saitoh, Atsushi Shiraishi, Yasuhiro Otomo, Satoshi Gando, the JAAM FORECAST Group   +12 more
doaj   +1 more source

Clinical study of anticoagulant therapy in patients with severe coronavirus disease: A single-center retrospective analysis

Vascular Investigation and Therapy, 2021
OBJECTIVE: The prognosis of COVID-19 is related to thrombotic events. This study investigated prognostic risk factors, anticoagulant therapy effects, and potential instruction of treatment or prognostic with D-dimer in patients with severe COVID-19 ...
Peng Zhou, Chuan-Qi Cai, Jin-Song Li, Huan-Zong Jiang, Zun-Xiang Ke, Shan Zhang, Zhong-Jian Wang, Chao Yang, Qin Li, Yi-Qing Li   +9 more
doaj   +1 more source